Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 24 | Perros EvangelosChief Financial Officer |  PGYPagaya Technologies Ltd.Open-market sale | SELL | $147K 13.0K sh | Apr 2, 2026 |
| 23 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 3,348 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 22 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $1.90M 49.3K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 22 | Raghunathan VivekSVP, Engineering | SNOWSnowflake Inc. Open-market sale · 10b5-1 plan | SELL | $592K 3,876 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 21 | Lozinski Jeffrey William10% Owner |  KSEZKinetic Seas Inc.Open-market sale | SELL | $1,500 50.0K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 21 | Lozinski Jeffrey William10% Owner | KSEZKinetic Seas Inc. Open-market sale | SELL | $2,160 61.7K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 20 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,320 300 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 17 | Beneski Benjamin MachinasSVP, Chief Technical Officer |  ALLOAllogene Therapeutics, Inc.Open-market sale | SELL | $7,168 2,867 sh | Apr 2, 2026 traded Mar 31, 2026 |
| 15 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 2,200 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 13 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 668 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 8 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,101 300 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 0 | Schubach Sarah ElizabethChief Accounting Officer |  DBXDROPBOX, INC.Open-market sale · 10b5-1 plan | SELL | $32K 1,416 sh | Apr 2, 2026 traded Mar 31, 2026 |
| 51 | Zagari RaffaeleDirector |  SBLKStar Bulk Carriers Corp.Open-market sale | SELL | $2.62B 11.5K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 38 | Longhito ChristopherFMR SVP & CSCO |  GICGLOBAL INDUSTRIAL CoOpen-market sale | SELL | $186K 5,985 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 38 | Davis ZachEVP & CFO |  LNGCheniere Energy, Inc.Open-market sale | SELL | $8.70M 29.0K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 35 | Longhito ChristopherFMR SVP & CSCO | GICGLOBAL INDUSTRIAL Co Open-market sale | SELL | $26K 819 sh | Apr 1, 2026 traded Mar 23, 2026 |
| 35 | Longhito ChristopherFMR SVP & CSCO | GICGLOBAL INDUSTRIAL Co Open-market sale | SELL | $8,857 286 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 34 | Longhito ChristopherFMR SVP & CSCO | GICGLOBAL INDUSTRIAL Co Open-market sale | SELL | $91K 2,927 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 34 | Longhito ChristopherFMR SVP & CSCO | GICGLOBAL INDUSTRIAL Co Open-market sale | SELL | $62K 1,984 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 32 | Buonanno Franck JeanVice-President, Global Sales |  LAESSEALSQ CorpOpen-market sale · 10b5-1 plan | SELL | $24K 10.0K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 32 | Puylaert KevinChief Sales Officer |  SOPHSOPHiA GENETICS SAOpen-market sale | SELL | $14.13 3 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 27 | Savitz RyanEVP, CFO & CBO |  DNTHDianthus Therapeutics, Inc. /DE/Open-market sale · 10b5-1 plan | SELL | $5.02M 59.8K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 27 | Longhito ChristopherFMR SVP & CSCO | GICGLOBAL INDUSTRIAL Co Open-market sale | SELL | $11K 364 sh | Apr 1, 2026 traded Mar 26, 2026 |
| 27 | Cree BrianPresident & Interim CEO |  VTSVitesse Energy, Inc.Open-market sale | SELL | $1.31M 70.1K sh | Apr 1, 2026 traded Mar 30, 2026 |
| 27 | Savitz RyanEVP, CFO & CBO | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $1.65M 19.5K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 26 | Noci DarleneChief Development Officer |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $291K 2,968 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 26 | Xiang BiboChief Technology Officer |  ATHMAutohome Inc.Open-market sale | SELL | $5,314 1,240 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 26 | Zeng YanChief Financial Officer | ATHMAutohome Inc. Open-market sale | SELL | $12K 2,704 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 26 | Sabar Karimah EsDirector |  CAPRCAPRICOR THERAPEUTICS, INC.Open-market sale · 10b5-1 plan | SELL | $1.85M 61.3K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 24 | Cree BrianPresident & Interim CEO | VTSVitesse Energy, Inc. Open-market sale | SELL | $926K 50.0K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 24 | Read BrianChief Financial Officer |  SERVServe Robotics Inc. /DE/Open-market sale | SELL | $10K 1,263 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 24 | Savitz RyanEVP, CFO & CBO | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $619K 7,232 sh | Apr 1, 2026 traded Mar 31, 2026 |
| 23 | Noci DarleneChief Development Officer | NUVLNuvalent, Inc. Open-market sale · 10b5-1 plan | SELL | $247K 2,532 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 23 | Longhito ChristopherFMR SVP & CSCO | GICGLOBAL INDUSTRIAL Co Open-market sale | SELL | $995 32 sh | Apr 1, 2026 traded Mar 27, 2026 |
| 22 | Sabar Karimah EsDirector | CAPRCAPRICOR THERAPEUTICS, INC. Open-market sale · 10b5-1 plan | SELL | $1.67M 53.7K sh | Apr 1, 2026 traded Apr 1, 2026 |
| 21 | Yaacobi TalDirector |  VLNValens Semiconductor Ltd.Open-market sale | SELL | $1,554 1,400 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 20 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $3.55M 1.00M sh | Apr 1, 2026 traded Mar 31, 2026 |
| 19 | Savitz RyanEVP, CFO & CBO | DNTHDianthus Therapeutics, Inc. /DE/ Open-market sale · 10b5-1 plan | SELL | $1.72M 21.8K sh | Apr 1, 2026 traded Mar 31, 2026 |
| 19 | Dandekar AtulCSBO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $196K 6,710 sh | Apr 1, 2026 traded Mar 30, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.63M 1.00M sh | Apr 1, 2026 traded Apr 1, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
MTDRMatador Resources CoNov 5 – Nov 56 insiders$507K
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K